American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer

Keywords

Medicine, Breast cancer, Guideline, Estrogen receptor, Oncology

References

• Immunohistochemical and molecular subtypes of breast cancer in Nigeria秘砂 山崎, 孝男 森山, 清久仁 河内谷 — 2008
• Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors.McCarty Ks, Éva Szabó, Flowers Jl — 1986
• Prognostic usefulness of estrogen receptor immunocytochemical assays for human breast cancer.Eugene R. DeSombre, Susan M. Thorpe, Carsten Rose — 1986
• Recommendations for validating estrogen and progesterone receptor immunohistochemistry assays.Patrick L. Fitzgibbons, Douglas A. Murphy, M. Elizabeth H. Hammond — 2010
• Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer.Jennet Harvey, Gary M. Clark, C. Kent Osborne — 1999
• Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies.McCarty Ks, Miller Ls, Cox Eb — 1985
• Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials.2005
• Regulatory issues in tumor marker development.Steven Gutman — 2002
• Immunohistochemical determination of oestrogen receptor: comparison of different methods of assessment of staining and correlation with clinical outcome of breast cancer patients.DM Barnes, WH Harris, Paul Smith — 1996
• Expanding priorities--confronting chronic disease in countries with low income.Gerard F. Anderson, Edward Chu — 2007
• Immunohistochemical assessment for estrogen receptor and progesterone receptor status in breast cancer: Analysis for a cut-off point as the predictor for endocrine therapyYoshinari Ogawa, Takuya Moriya, Yasuyuki Kato — 2004
• Progesterone receptors as a prognostic factor in stage II breast cancer.Gary M. Clark, William McGuire, Charles A. Hubay — 1983
• Markers of endocrine sensitivityDaniel F. Hayes — 2008
• High Progesterone Receptor Expression Correlates to the Effect of Adjuvant Tamoxifen in Premenopausal Breast Cancer PatientsMaria Stendahl, Lisa Rydén, Bo Nordenskjöld — 2006
• A simple index using video image analysis to predict disease outcome in primary breast cancerCoralie A. Lockwood, Carmela Ricciardelli, Wendy A. Raymond — 1999
• Computer-assisted immunocytochemical determination of breast cancer steroid receptors. Frozen sections vs paraffin sections.Antonio Cavaliere, Guido Bellezza, Ivana Ferri — 2001
• Oestrogen receptor in breast cancer: prognostic studies using a new immunohistochemical assayPhilip J. Cowen, J. Teasdale, Peter K. Jackson — 1990
• Predicting response to endocrine therapy in human breast cancer: a hypothesis.Kathryn B. Horwitz, William McGuire, Olof H. Pearson — 1975
• Reliability of immunohistochemical demonstration of oestrogen receptors in routine practice: interlaboratory variance in the sensitivity of detection and evaluation of scoring systemsAnthony Rhodes, Bharat Jasani, DM Barnes — 2000
• Frequency of oestrogen and progesterone receptor positivity by immunohistochemical analysis in 7016 breast carcinomas: correlation with patient age, assay sensitivity, threshold value, and mammographic screeningAnthony Rhodes, B Jasani, A J Balaton — 2000

Cited by

• Quantification of protein expression in cells and cellular subcompartments on immunohistochemical sections using a computer supported image analysis system.Martin Braun, Robert Kirsten, Niels J. Rupp — 2013
• Cancers du sein hormono-dépendants: quels biomarqueurs tissulaires utiles dans la prise en charge ?Jacqueline Lehmann‐Che — 2011
• The reliability of rabbit monoclonal antibodies in the immunohistochemical assessment of estrogen receptors, progesterone receptors, and HER2 in human breast carcinomas.Fernando López Lerdo de Tejada — 2010
• Measurement of ER and PR status in breast cancer using the QuantiGene2.0 assayTamar Sarvide Plano — 2011
• NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology.W. J. Rorabaugh — 2011
• Comparison of Molecular Analysis and Histopathology for Axillary Lymph Node Staging in Primary Breast Cancer: Results of the B-CLOSER-I StudyHéctor Heras — 2012
• A 50-Gene Intrinsic Subtype Classifier for Prognosis and Prediction of Benefit from Adjuvant TamoxifenAna Coêlho Vieira Selva, Ana Carolina Perrusi Brandão — 2012
• Sample parameters affecting the clinical relevance of RNA biomarkers in translational breast cancer researchJ Jen, J Sihombing, Sun On Chan — 2012
• Metabolic interaction between cancer cells and stromal cells according to breast cancer molecular subtype健太 滝沢, 雄二 長谷見, 伸一 土屋 — 2013
• Gross cystic disease fluid protein 15 (GCDFP-15) expression in breast cancer subtypesSaad Hannan — 2014
• Mouse monoclonal antibodies against estrogen receptor.Daniel B. Hall — 2014
• A multifunctional polymeric nanotheranostic system delivers doxorubicin and imaging agents across the blood-brain barrier targeting brain metastases of breast cancer.José Ignacio Martín Benito, Rafael González Rodríguez — 2014
• Oxidative Stress-Mediated Apoptosis Induced by Ethanolic Mango Seed Extract in Cultured Estrogen Receptor Positive Breast Cancer MCF-7 CellsRichard White, S Perrone — 2015
• Intra-tumor genetic heterogeneity and alternative driver genetic alterations in breast cancers with heterogeneous HER2 gene amplificationТумаков Николай Николаевич — 2015
• Relative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1-98 Trial.Otto Metzger, Anita Giobbie‐Hurder, Elizabeth Mallon — 2015
• Correlation of Physical Activities and Breast Cancer Characteristics: A Prospective Analysis with Special Focus on Triple Negative Breast CancerBertrand Schatz — 2015
• The Values of Combined and Sub-Stratified Imaging Scores with Ultrasonography and Mammography in Breast Cancer Subtypes正彦 湯浅 — 2015
• Role of Sphk1 in the malignant transformation of breast epithelial cells and breast cancer progression.慎吾 中村 — 2014
• Genetic events in the progression of adenoid cystic carcinoma of the breast to high-grade triple-negative breast cancerJohn S. Ruskay — 2016
• Comparison of the FDA and ASCO/CAP Criteria for HER2 Immunohistochemistry in Upper Urinary Tract Urothelial CarcinomaV. B. Matveev — 2016

Related papers

• Molecular Subtypes by Immunohistochemical for Iraqi Women with Breast CancerIman Al-Bedairy, Abdul Hussein Moyet Al-Faisal, Hussien Raof AL-Gazali — 2020
• Significance of estrogen receptor subtypes in breast tumorigenesis and progressionWeiliang Sun, Chijiang Gu, Min-Ming Xia — 2014
• Human breast tumors: a comparison between the biochemical method of measuring estrogen and progesterone receptors and that of an immunohistochemical method.M. J. Lacombe, J Delarue, H Mouriesse — 1989
• Immunohistochemical determination of estrogen and progesterone receptor status in breast cancer.Marvin Tesch, Allam Shawwa, Rosemary Henderson — 1993
• Immunohistochemical detection of estrogen and progesterone receptors in endometriotic tissuePedro‐Antonio Regidor, M. Regidor, K. Metz — 1994
• Immunohistochemical expression of progesterone and estrogen receptors in meningiomas.Aleksandra Omulecka, W Papierz, Agnieszka Nawrocka-Kunecka — 2006
• Computer-aided evaluation of the correlation between MRI morphology and immunohistochemical biomarkers or molecular subtypes in breast cancerSen Jiang, You-jia Hong, Fan Zhang — 2017
• Expression and significance of ER、PR and Her-2 in breast cancer tissueDehong Zou — 2008
• Analysis of the effect of progesterone in vivo on estrogen receptor distribution in the rat anterior pituitary and hypothalamus.Elizabeth J. Smanik, H. KENNETH YOUNG, Thomas G. Muldoon — 1983